home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.25 +0.48 (+0.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

49 50 Next >

Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday ↗

March 06, 2024

With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

March 05, 2024

From DexCom, Inc.

Via Business Wire

Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move ↗

March 03, 2024

With patience, these stocks will provide outsized returns to investors.

Via The Motley Fool

Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla ↗

March 01, 2024

U.S. stock market continues bull run, hitting record highs for S&P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones.

Via Benzinga

Topics ETFs Stocks

NASDAQ:DXCM qualifies as a high growth stock and is consolidating. ↗

February 26, 2024

Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.

Via Chartmill

Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

February 21, 2024

Via Benzinga

3 Telehealth Stocks With Room to Run in 2024 ↗

February 29, 2024

Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio.

Via InvestorPlace

Dexcom Announces Upcoming Conference Presentation

February 27, 2024

From DexCom, Inc.

Via Business Wire

DexCom: A Winner In Diabetes Management ↗

February 25, 2024

Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820...

Via Talk Markets

Got $1,000? Buy These Hot Growth Stocks Before They Take Off ↗

February 22, 2024

If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.

Via The Motley Fool

Xylem, DexCom And 2 Other Stocks Insiders Are Selling ↗

February 22, 2024

The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

DexCom: Q4 Earnings Insights ↗

February 08, 2024

Via Benzinga

Prediction: 2 Stocks That Could Trounce the Market ↗

February 08, 2024

They have done it before.

Via The Motley Fool

Earnings Scheduled For February 8, 2024 ↗

February 08, 2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.

Via Benzinga

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗

February 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

Via InvestorPlace

Wall Street is surprisingly most bullish on these 3 Nasdaq stocks

February 14, 2024

Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves

Via MarketBeat

These 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now? ↗

February 13, 2024

Expectations are high for companies making blood sugar monitors and business automation software.

Via The Motley Fool

Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names ↗

February 12, 2024

Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready...

Via The Motley Fool

If You Invested $100 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗

February 07, 2024

Via Benzinga

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?. ↗

January 25, 2024

DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Evaluating NASDAQ:DXCM for Growth Investment Opportunities. ↗

January 25, 2024

Why the growth investor may take a look at NASDAQ:DXCM.

Via Chartmill

2 No-Brainer Healthcare Stocks to Buy Right Now ↗

February 10, 2024

Companies in the healthcare industry tend to generate returns in a wide range of market environments.

Via The Motley Fool

Continuous Glucose Monitor Maker Dexcom's Q4 Profit Triples On Volume Growth And New Customer Additions ↗

February 09, 2024

Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform...

Via Benzinga

DexCom (DXCM) Q4 2023 Earnings Call Transcript ↗

February 08, 2024

DXCM earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 08, 2024

From DexCom, Inc.

Via Business Wire

3 Nasdaq stocks likely to make big earnings splashes

February 07, 2024

Here we look at a few examples of high beta, high standard deviation Nasdaq-100 stocks that are poised to have volatile earnings moves in the near future.

Via MarketBeat

Topics Artificial Intelligence Economy

2 Phenomenal Stocks to Buy for the New Year ↗

February 03, 2024

These growth stocks are raking in profits and cash as leaders in their respective industries.

Via The Motley Fool

Stryker Stock Sees Relative Strength Rating Jump To 84 ↗

February 01, 2024

The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84.

Via Investor's Business Daily

These 2 Growth Stocks Are Brilliant Buys for the New Year ↗

January 23, 2024

Business is booming for these stocks, and investors might want to stop and take note.

Via The Motley Fool

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time

January 23, 2024

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com